Trey Foskett
About Trey Foskett
Trey Foskett - Chief Executive Officer
Trey Foskett serves as the Chief Executive Officer, bringing innovative approaches to the field of directed evolution and enzyme engineering. His leadership focuses on advancing novel genomic applications, emphasizing practical and groundbreaking methods in these domains.
Trey Foskett's Role in Directed Evolution and Enzyme Engineering
Trey Foskett applies pioneering methods in directed evolution and enzyme engineering. His work aims to enable novel genomic applications, reflecting a commitment to advancing science and biotechnological processes. His expertise in these areas has positioned him as a leader in the industry.
Co-founder and Chief Technology Officer of Kapa Biosystems
Trey Foskett co-founded Kapa Biosystems, where he served as Chief Technology Officer. In this role, he led the company's global commercial and scientific teams, driving the company towards significant achievements in biotechnology. Under his guidance, Kapa Biosystems grew to be a prominent entity before its acquisition by Roche.
Trey Foskett at Roche North America
Following the acquisition of Kapa Biosystems by Roche in 2015, Trey Foskett transitioned to the role of Vice President of Sequencing and Life Science Commercial Operations for Roche North America. In this capacity, he oversaw sequencing operations, bringing his extensive knowledge and experience to enhance commercial operations within the business unit.
Trey Foskett's Patents and Innovations
Trey Foskett is listed as an inventor on three issued patents and has two additional patents pending. His contributions to patent work highlight his innovative mindset and dedication to advancing technological capabilities within his field. These patents underscore his commitment to research and development in enzyme engineering and genomics.